BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12545628)

  • 21. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy.
    Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y
    Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcomes following radical cystectomy for primary nontransitional cell carcinoma of the bladder compared to transitional cell carcinoma of the bladder.
    Rogers CG; Palapattu GS; Shariat SF; Karakiewicz PI; Bastian PJ; Lotan Y; Gupta A; Vazina A; Gilad A; Sagalowsky AI; Lerner SP; Schoenberg MP
    J Urol; 2006 Jun; 175(6):2048-53; discussion 2053. PubMed ID: 16697800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis.
    Abdel-Latif M; Abol-Enein H; El-Baz M; Ghoneim MA
    J Urol; 2004 Jul; 172(1):85-9. PubMed ID: 15201743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
    Suzuki K; Morita T; Tokue A
    Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    J Clin Oncol; 2005 Apr; 23(10):2358-65. PubMed ID: 15800327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer.
    Cho KS; Seo HK; Joung JY; Park WS; Ro JY; Han KS; Chung J; Lee KH
    J Urol; 2009 Dec; 182(6):2625-30. PubMed ID: 19836779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL; Lin DW; Porter MP
    Cancer; 2008 Jun; 112(11):2401-8. PubMed ID: 18383515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Infiltrating bladder carcinoma with metastatic lymph node involvement: radical treatment and survival].
    de Castro Barbosa F; Sánchez de la Muela P; Rosell Costa D; Aguera Fernández L; Isa Kroon W; Robles García JE; Zudaire Bergera JJ; Berián Polo JM
    Actas Urol Esp; 1992 Jan; 16(1):58-62. PubMed ID: 1590075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early versus deferred cystectomy for initial high-risk pT1G3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?
    Denzinger S; Fritsche HM; Otto W; Blana A; Wieland WF; Burger M
    Eur Urol; 2008 Jan; 53(1):146-52. PubMed ID: 17624657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic factors of invasive bladder cancer with lymph node invasion].
    Lacroix B; Rusch P; Cerisier A; Pages A; Armand C; Tostain J
    Prog Urol; 2002 Sep; 12(4):615-20. PubMed ID: 12463120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radical cystectomy for urothelial bladder cancer: prognostic impact of lymph node metastasis and soft tissue surgical margins].
    Toledano H; Bastide C; Thoulouzan M; Arroua F; Carcenac A; Ragni E; Huyghe E; Plante P; Rossi D; Soulie M
    Prog Urol; 2012 Oct; 22(12):705-10. PubMed ID: 22999117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy.
    Resorlu B; Beduk Y; Baltaci S; Ergun G; Talas H
    BJU Int; 2009 Feb; 103(4):480-3. PubMed ID: 18990160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM; Lopez-Corona E; Bochner BH; Herr HW; Donat SM; Russo P; Dalbagni G; Sogani PC
    J Urol; 2004 Sep; 172(3):878-81. PubMed ID: 15310988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K; Sakai I; Hara I; Eto H; Miyake H
    Int J Urol; 2005 Mar; 12(3):250-5. PubMed ID: 15828951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.